Articles

Plans for private club at San Francisco’s Transamerica Pyramid hit by lawsuit

Michael Shvo is sued by a partner involved in creating an exclusive club at San Francisco’s famed Transamerica Pyramid

Those new AI-powered Windows PCs really might be Apple ‘Mac killers’

Qualcomm is strongly positioned, while AMD and Intel may be vulnerable.

The IRS apologized to billionaire Ken Griffin, but the agency struggles to help everyday taxpayers with this ‘unconscionable’ problem

Taxpayers are facing longer wait times for the IRS to resolve identity theft cases, a new report from the National Taxpayer Advocate finds

GameStop’s trading volume slips to lowest level since early May

GameStop Corp.’s trading volume fell to its lowest level in nearly eight weeks on Wednesday as the dust continues to settle after the recent meme-stock frenzy.

What should Biden and Trump say to America’s most important voting bloc — seniors?

Presidential debate topics crucial to older Americans—Social Security, Medicare and Medicaid—must get some air time

Apple is bucking the trend on AI — and that could help its stock

A Rosenblatt analyst sees Apple deviating from the path on artificial intelligence in at least two ways — both of which he says could help the consumer-electronics stock.

Why bitcoin and small-cap stocks could rally together

A weekly look at the most important news and moves in crypto, and what’s on the horizon in digital assets.

Most-active gold futures mark lowest settlement since early May

Gold futures tallied back-to-back losses on Wednesday, sending the most-active contract to its lowest finish in more than seven weeks, as prices on the spot market dipped below a key technical level of $2,300 an ounce.

Nvidia controls the AI universe now — but these tech giants will lead the next boom

Simple, out-of-the box AI to run a business will be a moneymaker for software providers.

Amazon crosses above $2 trillion market cap as only fifth U.S. company to do so

After all the recent attention on Nvidia’s market-capitalization milestones, now it could be Amazon’s time to shine.

Moderna’s stock falls after data shows biotech’s RSV vaccine trails rivals after 18 months

Moderna Inc.’s stock fell 6.4% Wednesday, after the company said that its respiratory syncytial virus, or RSV, shot showed 50% efficacy in preventing the illness after 18 months.

You think your 401(k) looks bad? These people are doing worse — don’t be one of them.

Retirement may be out of reach for the average person lacking financial education and resources.
1 1,025 1,026 1,027 1,028 1,029 2,311